drugset / Trial / NCT01058083
Safety Study of BMS-770767 in Subjects With Hypercholesterolemia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)
Timeline
- Start
- 2010-05
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-770767 | Unknown | 15 mg | Oral |
| Subject | BMS-770767 | Unknown | 50 mg | Oral |
| Subject | BMS-770767 | Unknown | 150 mg | Oral |